P53 vs NF-κB: the role of nuclear factor-kappa B in the regulation of p53 activity and vice versa

被引:0
作者
Giovanna Carrà
Marcello Francesco Lingua
Beatrice Maffeo
Riccardo Taulli
Alessandro Morotti
机构
[1] University of Turin,Department of Clinical and Biological Sciences
[2] University of Turin,Department of Oncology
来源
Cellular and Molecular Life Sciences | 2020年 / 77卷
关键词
NF-κb; P53; Apoptosis; Crosstalk;
D O I
暂无
中图分类号
学科分类号
摘要
The onco-suppressor p53 is a transcription factor that regulates a wide spectrum of genes involved in various cellular functions including apoptosis, cell cycle arrest, senescence, autophagy, DNA repair and angiogenesis. p53 and NF-κB generally have opposing effects in cancer cells. While p53 activity is associated with apoptosis induction, the stimulation of NF-κB has been demonstrated to promote resistance to programmed cell death. Although the transcription factor NF-κB family is considered as the master regulator of cancer development and maintenance, it has been mainly studied in relation to its ability to regulate p53. This has revealed the importance of the crosstalk between NF-κB, p53 and other crucial cell signaling pathways. This review analyzes the various mechanisms by which NF-κB regulates the activity of p53 and the role of p53 on NF-κB activity.
引用
收藏
页码:4449 / 4458
页数:9
相关论文
共 469 条
[1]  
Joerger AC(2016)The p53 pathway: origins, inactivation in cancer, and emerging therapeutic approaches Annu Rev Biochem 85 375-404
[2]  
Fersht AR(2017)Mutant p53 in cancer: accumulation, gain-of-function, and therapy J Mol Biol 429 1595-1606
[3]  
Yue X(2015)Regulation of the p53 response and its relationship to cancer Biochem J 469 325-346
[4]  
Zhao Y(2016)Signaling via the NFκB system Wiley Interdiscip Rev Syst Biol Med 8 227-241
[5]  
Xu Y(2017)30 Years of NF-κB: a blossoming of relevance to human pathobiology Cell 168 37-57
[6]  
Zheng M(2018)NF-kappaB: Two sides of the same coin Genes (Basel) 9 24-324
[7]  
Feng Z(2018)NF-κB, inflammation, immunity and cancer: coming of age Nat Rev Immunol 18 309-1040
[8]  
Hu W(2008)Double-edged swords as cancer therapeutics: simultaneously targeting p53 and NF-kappaB pathways Nat Rev Drug Discov 7 1031-3652
[9]  
Meek DW(2010)p53 and NF-κB: different strategies for responding to stress lead to a functional antagonism FASEB J 24 3643-20074
[10]  
Mitchell S(2016)p53 and the carcinogenicity of chronic inflammation Cold Spring Harb Perspect Med 6 a026161-897